> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Malaria Drug NDA
- URL: https://www.fdaweb.com/panel-to-review-malaria-drug-nda/
- Published: 2018-06-26T12:00:00.000Z
- Updated: 2026-09-15T00:15:56.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141771

*Federal Register* notice: FDA has announced a 7/26 Antimicrobial Drugs Advisory Committee meeting. Panel members are scheduled to review Agenda: The committee will discuss a 60 Degrees Pharmaceuticals NDA for tafenoquine tablets, 100 mg, for the proposed indication of preventing malaria in adults for up to six months of continuous dosing. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-06-26/pdf/2018-13711.pdf?ref=fdaweb.com).